Methemoglobinemia in Transplant Recipient Patients: Future of Dapsone as Pneumocystis carinii Pneumonia Prophylaxis

Abstract

Keywords

therapeutics education other transplant recipient body regions neoplasms hemic and lymphatic diseases

Get full access to this article

View all access options for this article.

References

Torabi

Campbell

Nair

Patel

Miura

Graham

. Dapsone-induced methemoglobinemia in two renal transplant recipients. Prog Transplant. 2019;29(3):289–290. doi:10.1177/1526924819855365.

Mitsides

Green

Middleton

, et al. Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought. Transpl Infect Dis. 2014;16(1):37–43. doi:10.1111/tid.12161.

Esbenshade

Shintani

Zhao

Smith

Friedman

. Dapsone-induced methemoglobinemia: a dose-related occurrence? Cancer. 2011;117(15):3485–3492. doi:10.1002/cncr.25904.

Plotkin

Buell

Njoku

, et al. Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review. Liver Transpl Surg. 1997;3(2):149–152.